Biotech: Page 43

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Pharmaceutical companies as well as their partners are feeling the heat. They are facing unprecedented challenges on a global scale. More so than ever, their business strategies are being put to the test. How well they do will depend on the resilience of their operations and the vision of their l...

    By Taren Grom • Nov. 22, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Medicare Incentives Push E-Prescribing to Top of Mind

    2008 VIEW on ESolutions EPRESCRIBING It’s no secret that thousands of private practice physicians throughout the country face a financial crunch. Declining reimbursement rates have produced a profoundly negative impact in several areas of healthcare — particularly in oncology, nephrology and othe...

    By PharmaVoice Team • Oct. 24, 2008
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Leonard Bell, M.D.,CEO of Alexion, is also the Principal Founder of the biopharmaceutical company, which was established in 1992.From 1991 to 1992, Dr.Bell was Codirector of the Program in Vascular Biology at the Yale University School of Medicine,where starting in 1990 he had also been an Assist...

    By PharmaVoice Team • Sept. 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Mark GLICKMAN Oscient Promotes Sales Executive Commercial stage pharmaceutical company Oscient Pharmaceuticals, Waltham, Mass., has promoted Mark Glickman to senior VP, sales and marketing, and corporate officer. Since joining Oscient in August 2007 as VP of sales, Mr. Glickman has be...

    By PharmaVoice Team • Sept. 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    October 15 3rd Leadership Summit on Medicare Enrollment and PDE Data Reconciliation Hilton Old Town, Alexandria, Va. PharmaVOICE subscribers receive $300 discount; register using keycode HYU957. For more information, contact Jodi Bova, Center for Business Intelligence, at 781-939-2563, email jodi...

    By PharmaVoice Team • Sept. 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Green Movement: Rethinking Chemistry

    BY DENISE MYSHKO Major pharmaceutical companies are working together to minimize the environmental impact of how they make their products. The GREEN MOVEMENT Rethinking Chemistry GREEN IS THE NEW BLACK. The push to make prescription drugs more efficient, cleaner, and safer is gaining momentum ami...

    By Denise Myshko • Aug. 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A New Era of Drug Safety

    BY DENISE MYSHKO NEW REGULATIONS IN THE UNITED STATES AND EUROPE HAVE TRIGGERED A NEED FOR BETTER TOOLS FOR THE COLLECTING, REPORTING,AND ANALYSIS OF PATIENT SAFETY DATA. As regulators around the globe demand more data on each drug’s profile, the need for technologies to support drug safety has b...

    By PharmaVoice Team • Aug. 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Jason Cohen joined GE Healthcare Financial Services in 2006 and is a Senior VP and Pharmaceuticals Analyst. In this role, he helps lead the GE corporate finance efforts within specialty pharma, generics, biotechnology, and outsourced services. Additionally, he provides guidance and oversight on v...

    By PharmaVoice Team • Aug. 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    4th Integrating Electronic Health Records and eClinical Technologies Conference Baltimore Marriott Waterfront Hotel,Baltimore For more information, contact Jasmaine John, ExL Pharma,at 2124006235, email [email protected], or visit exlpharma.com. September 1516 Biotech Patents Royal Sonesta Hote...

    By PharmaVoice Team • Aug. 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Safe-BioPharma Activates Electronic Identity Link Octagon Research Provides System for Submissions Targetbase Introduces Customized Direct-to-Patient Solutions Visual i|o Launches Portfolio Management System E-Upg...

    By PharmaVoice Team • Aug. 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Rules Change Again

    August 2008 VIEW on Medical Education THE FORUM News of Pfizer’s decision to eliminate all direct funding for physician CME programs provided by medical education and communication companies (MECCs) — the first such move by a major pharmaceutical company — has rattled even this most dynamic of se...

    By PharmaVoice Team • Aug. 20, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Cover

    PharmaVOICE PharmaVOICE 100 THE FORUM FOR THE INDUSTRY EXECUTIVE July/August 2008 SPECIAL ISSUE 100 of the Most Inspiring People www.pharmavoice.com Download PDF

    By PharmaVoice Team • July 28, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PharmaVOICE is delighted to publish the fourth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry. This issue has become one of my favorites and, from all accounts, one of yours as well. What’s not to love? This issue celebrates the men and women of...

    By Taren Grom • July 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Mentors

    Brian Corvino Mary Lacquaniti Lelia O’Connor Danita Sutton, Ph.D. MENTORING AND SHAPING THE CAREERS OF OTHERS ARE VENERABLE AND ADMIRABLE TALENTS. MENTORING TAKES PATIENCE, FORESIGHT, AND UNSELFISH DEVOTIONTO OTHERS’ SUCCESS and is a skill that is often unheralded — until now. We salute those who...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Valdo Arnera, M.D. Bill Byrom, Ph.D. Philip A. Garland Keith Howells Don Schenker Rodney Spady A creative and passionate approach to pioneering new areas of technology applications and new products has enabled Dr. Bill Byrom to engender real improvements in the drug development process. For the p...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers

    Julian Adams, Ph.D. Alain D. Baron, M.D. Martine Clozel, M.D. Jean-Jacques Garaud, M.D. Amir H. Kalali, M.D. Dennis Keith, Ph.D. Nick Kenny, Ph.D. Geert J.C.M. Kolvenbag M.D., Ph.D., F.F.P.M Evan Loh, M.D. Karen Seibert, Ph.D. The Researchers PRODUCTS BECOME BRANDS BECAUSE OF THE DEDICATION AND P...

    By PharmaVoice Team • July 24, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Clinical Operations: Bringing All of the Pieces Together

    6 June 20 08 VIEW on Clinical Operations THE FORUM A recentTufts CSDD study cites research showing that the cost to develop a new biopharmaceutical is now more than $1 billion. Accordingly, clinical organizations are under growing pressure to reduce research and development costs while accelerati...

    By PharmaVoice Team • June 9, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA Preview Showcase

    SPECIAL FEATURE DIA 44TH ANNUAL MEETING Representing more than 20,000 members worldwide involved in discovery, development, regulation, and marketing of bio/phar maceutical and related products, the Drug Information Association (DIA) each year has the significant task of designing an annual meeti...

    By PharmaVoice Team • May 28, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    THE OTC MARKET Plop,Plop, Fizz, Fizz Consumers are taking an increasingly active role in self medication because of rising healthcare costs, a large uninsured population, and ever more choices in OTC products. Purchasing OTC drugs also is more convenient and money is saved avoiding doctor’s visit...

    By PharmaVoice Team • May 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise your voice: Letters

    Digital Training With the emergence of digital technology as the fastest growing means of delivering brand marketing and messaging, digital training is one of the best investments agencies can make to address the increasing pressures and speed of change cited by so many of your experts in the Apr...

    By PharmaVoice Team • May 27, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Special Feature: HBA's 2008 Rising Stars

    BY TAREN GROM Nelson. CommonHealth. There is no magic formula, no set of qualities or attributes which when combined in exact pro portions spontaneously produces a leader. Cer tainly many leaders possess similar characteris tics — innovation, persuasion, charisma, etc. — but what sets a leader ap...

    By Taren Grom • April 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Seeding Early-Stage Research

    Future success in the pharmaceutical industry will hinge on the ability of companies to deliver novel products that meet patient needs. To do that, pharma companies are teaming up with biotech companies, launching their own biotech divisions, investing in genetics, and acquiring other companies, ...

    By Denise Myshko • April 30, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Michael V. Novinski became President and CEO of Emisphere Technologies in May 2007. Previously, he served as President of Organon USA with additional responsibility for worldwide business development and lifecycle management.While serving as Organon’s Director of Marketing and later as VP of Mark...

    By PharmaVoice Team • April 29, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    ONTHE CALENDAR May 1516 13th Annual Pharmaceutical &Biotech Licensing &Deal Making Summit Hyatt Regency NewBrunswick,New Brunswick,N.J. For more information, contact Cheryl KahanRadhuber,Strategic Research Institute, at 2129670095, email [email protected], or visit srinstitut...

    By PharmaVoice Team • April 29, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Immune Tolerance Institute (ITI), a new nonprofit company, is bringing economies of scale to translational and critical path science to build partnerships with the pharmaceutical and biotech industries, and accelerate the development of new ...

    By PharmaVoice Team • April 29, 2008